• Cy5-UTP for Axonal RNA Trafficking Studies

  2026-09-15

  Cy5-UTP enables direct fluorescent RNA probe synthesis for spatial studies of axonal RNP biology. This article connects Cyanine 5-uridine triphosphate labeling with the ANXA7–dynein–TIA1 trafficking mechanism while distinguishing localization assays from live transport measurements.

• Phalloidin B7678: Practical F-Actin Guide

  2026-09-14

  Phalloidin B7678 is a cyclic heptapeptide toxin used to stabilize and visualize filamentous actin in fixed, permeabilized cells, tissue sections, and cell-free assays. It is intended for endpoint cytoskeleton visualization, not live-cell imaging or experiments requiring reversible actin remodeling.

• Wnt–NR2F2–GPX4 Axis in Brain Metastasis

  2026-09-14

  The reference study identifies a metabolic and transcriptional mechanism underlying acquired platinum resistance in lung cancer-derived brain metastases. Its evidence links glutathione overconsumption, GPX4 and GSTM1 activity, ferroptosis suppression, and Wnt/NR2F2-dependent GPX4 transcription, suggesting a rationale for combining platinum therapy with GPX4-directed intervention.

• IP3R/Ca2+/STAT3 in Nanoplastic–Cadmium Toxicity

  2026-09-13

  A 2026 Toxicology study links polystyrene nanoplastic–cadmium co-exposure to intestinal apoptosis through the IP3R/Ca2+/STAT3 axis. Complementary C. elegans and Caco-2 experiments, including calcium chelation, provide functional evidence that intracellular Ca2+ dysregulation contributes to the toxic response.

• Wnt agonist 1: Applied Research Workflow

  2026-09-12

  Wnt agonist 1, also known as BML-284, provides a controllable small-molecule route to canonical Wnt signaling pathway activation in differentiation, developmental, and cancer models. This workflow connects TCF reporter measurements with the glutathione, GPX4, and platinum-resistance biology highlighted in a lung cancer brain-metastasis study.

• G007-LK: An Assay-First Tankyrase Inhibitor

  2026-09-11

  G007-LK is a selective tankyrase 1/2 inhibitor for dissecting Wnt, β-catenin, and Hippo pathway biology. This assay-first guide connects molecular mechanism with model selection, orthogonal readouts, and interpretation of colorectal and hepatocellular carcinoma data.

• 7ACC2 for Reliable Cancer Metabolism Assays

  2026-09-11

  This scenario-driven guide explains how 7ACC2, SKU B4868, can support reproducible studies of lactate transport, mitochondrial pyruvate handling, cell viability, and cancer metabolism. It separates product-backed evidence from workflow recommendations so researchers can interpret metabolic and cytotoxicity endpoints without overclaiming mechanism.

• Exendin-4 A3408: Reliable Beta-Cell Assays

  2026-09-10

  This scenario-driven guide explains how Exendin-4 (SKU A3408) can improve the design and interpretation of beta-cell, viability, proliferation, and cytotoxicity workflows. It connects dose selection, aqueous handling, cAMP biology, assay controls, and vendor evaluation to practical laboratory decisions.

• Monomethyl auristatin E in State-Aware ADC Studies

  2026-09-10

  Monomethyl auristatin E (MMAE) enables highly sensitive payload-response studies when free drug, antibody-drug conjugate delivery, and tumor cell state are evaluated separately. This workflow connects tubulin-directed cytotoxicity with the EBV-associated plasticity biology of nasopharyngeal carcinoma while clearly distinguishing established evidence from translational hypotheses.

• AR and ARv7 in TNBC: EPI-001 Evidence

  2026-09-09

  This 2025 study integrates patient immunohistochemistry, TCGA-BRCA analysis, and MDA-MB-231 experiments to examine AR and ARv7 in triple-negative breast cancer. Its findings associate ARv7, especially nuclear ARv7, with adverse outcomes and show that EPI-001 and enzalutamide modulate metastasis and epithelial–mesenchymal transition markers through pathways involving ROCK, NF-κB, and c-Myc.

• CFTRinh-172 Workflows for CFTR Transport Studies

  2026-09-09

  CFTRinh-172 enables rapid, reversible separation of CFTR channel activity from trafficking and signaling effects. This guide translates that distinction into epithelial transport workflows, surface-abundance controls, secretory diarrhea models, and practical troubleshooting strategies.

• CCCP: Mitochondrial Proton Gradient Uncoupler

  2026-09-08

  CCCP, also called carbonyl cyanide m-chlorophenyl hydrazine, dissipates the mitochondrial proton gradient and uncouples ATP production from respiratory electron flow. Its strongest research use is as a controlled bioenergetic perturbation, not as a clinical or diagnostic reagent.

• DeferoxamineB: Iron Chelation in Cancer Research

  2026-09-08

  Deferoxamine is an Fe(III)-chelating research compound used to test iron dependence, oxidative stress, and regulated cell death in biological models. DeferoxamineB supports ferroptosis-focused assay design, but results should not be interpreted as direct evidence of cuproptosis, apoptosis, or autophagy without pathway-specific controls.

• GSK621: A Practical AMPK Agonist Workflow

  2026-09-07

  GSK621 provides a direct way to interrogate AMPK-driven metabolic remodeling, mTORC1 suppression, autophagy, and apoptosis in AML and immunometabolic models. This workflow connects target engagement assays with practical optimization steps and the 25-hydroxycholesterol–AMPK pathway described in tumor-associated macrophages.

• Azithromycin Workflows for Infection Research

  2026-09-07

  Azithromycin supports practical workflows spanning bacterial infection research, resistance screening, analytical quality control, and investigational trypanosomosis studies. This guide connects its 50S-ribosome mechanism with solvent handling, impurity control, washout experiments, and assay-specific troubleshooting.

8320 records 1/555 page Next 12345 下5页 Last page